|
Volumn 11, Issue 3, 2005, Pages 245-
|
Reports on nevirapine threaten public health
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
NEVIRAPINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
DEVELOPING COUNTRY;
DISEASE TRANSMISSION;
DRUG EFFICACY;
DRUG SAFETY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
PRIORITY JOURNAL;
UGANDA;
ADULT;
ANTI-HIV AGENTS;
CLINICAL TRIALS;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
GOVERNMENT PUBLICATIONS;
HIV INFECTIONS;
HUMANS;
INFANT, NEWBORN;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NEVIRAPINE;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PUBLIC HEALTH;
UNITED STATES;
|
EID: 20144389049
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0305-245 Document Type: Letter |
Times cited : (1)
|
References (8)
|